Becton Dickinson and Co (NYSE:BDX)
| 247.89 Delayed Data As of Jul 05 |  -0.04 / -0.02%Today’s Change | 229.24 Today|||52-Week Range 277.29 | +1.11% Year-to-Date |
Latest BDX News | Press Releases
| Rempart Asset Management Inc. Goes on Buying Spree in 2nd Quarter Jul 01 / GuruFocus News - Paid Partner Content | BD (BDX) Integrates Innovative Solution to Boost Patient Care Jun 23 / Zacks.com - Paid Partner Content |
| BD's (BDX) New Combination Test to Boost Patient Outcome Jul 01 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 247.93 |
| Today’s open | 249.55 |
| Day’s range | 243.87 - 250.14 |
| Volume | 777,657 |
| Average volume (3 months) | 1,188,883 |
| Market cap | $71.8B |
Data as of 3:59pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | +151.71% |
| Earnings growth (this year) | -11.30% |
| Earnings growth (next 5 years) | +6.63% |
| Revenue growth (last year) | +18.29% |
| P/E ratio | 39.0 |
| Price/Sales | 3.55 |
| Price/Book | 3.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | +0.01 | +0.03% |
| BAXBaxter International... | +0.01 | +0.02% |
| DXCMDexcom Inc | +0.83 | +1.07% |
| WSTWest Pharmaceutical ... | -0.04 | -0.01% |
Data as of 4:02pm ET, 07/05/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | $2.50 |
| Annual revenue (last year) | $20.2B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 10.33% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |
Forecasts
